| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/20/2001 | WO2001068847A1 Novel mass receptor-analogous proteins and dnas thereof |
| 09/20/2001 | WO2001068846A2 Transcription activator of the cited family |
| 09/20/2001 | WO2001068845A2 Inflammation-inducible hybrid promoters, vectors containing same and uses thereof |
| 09/20/2001 | WO2001068844A2 Regulation of human leukotriene b4-like g protein-coupled receptor |
| 09/20/2001 | WO2001068843A1 Regulation of human galanin receptor-like g protein coupled receptor |
| 09/20/2001 | WO2001068842A2 Regulation of human p2y-like gpcr protein |
| 09/20/2001 | WO2001068841A2 Human dcc-like proteins |
| 09/20/2001 | WO2001068840A2 REGULATION OF HUMAN DIAZEPAM BINDING INHIBITOR/ACYL-CoA-LIKE PROTEIN |
| 09/20/2001 | WO2001068839A2 Regulation of human lipoxin a4 receptor-like protein |
| 09/20/2001 | WO2001068838A1 A novel polypeptide, a human excitatory amino acids transporter 16 and the polynucleotide encoding the polypeptide |
| 09/20/2001 | WO2001068837A2 Antisense oligonucleotides of the human chk1 gene and uses thereof |
| 09/20/2001 | WO2001068836A2 Methods and compositions for rna interference |
| 09/20/2001 | WO2001068835A2 Method for modifying a nucleic acid |
| 09/20/2001 | WO2001068833A2 Recombinant hhv8 dna |
| 09/20/2001 | WO2001068832A1 Method of cleaving single-stranded rna and kit |
| 09/20/2001 | WO2001068831A2 Effective nuclear reprogramming in mammals |
| 09/20/2001 | WO2001068828A2 Compositions and methods for regulated protein expression in gut |
| 09/20/2001 | WO2001068827A1 A process for the production of human interferon alpha from genetically engineered yeast |
| 09/20/2001 | WO2001068826A2 Protoporphyrinogen oxidase ('protox') genes |
| 09/20/2001 | WO2001068825A1 Human nim1 kinase |
| 09/20/2001 | WO2001068824A2 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 09/20/2001 | WO2001068821A2 Novel subtilase enzymes having an improved wash performance on egg stains |
| 09/20/2001 | WO2001068820A1 Altered strain of the modified vaccinia virus ankara (mva) |
| 09/20/2001 | WO2001068819A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine |
| 09/20/2001 | WO2001068818A2 Hcv ns2/3 fragments and uses thereof |
| 09/20/2001 | WO2001068816A1 Human histamine h3 gene variant-3 |
| 09/20/2001 | WO2001068815A1 Embryonic stem cells and neural progenitor cells derived therefrom |
| 09/20/2001 | WO2001068814A2 Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same |
| 09/20/2001 | WO2001068812A2 Methods of stimulating cartilage formation |
| 09/20/2001 | WO2001068810A1 Phosphorus-controllable recombinant expression of polypeptides in plants |
| 09/20/2001 | WO2001068807A2 Identification of in vivo dna binding loci of chromatin proteins using a tethered nucleotide modification enzyme |
| 09/20/2001 | WO2001068806A2 26934, a novel cytidine deaminase-like molecule and uses thereof |
| 09/20/2001 | WO2001068805A2 Human olfactory receptors and genes encoding same |
| 09/20/2001 | WO2001068802A2 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 09/20/2001 | WO2001068710A1 Monoclonal antibodies to the human ldl receptor, their production and use |
| 09/20/2001 | WO2001068708A2 Human and humanized fap-alpha-specific antibodies |
| 09/20/2001 | WO2001068707A1 Human hepatocyte growth factor activator inhibitor homologue |
| 09/20/2001 | WO2001068706A1 Melanin concentrating hormone receptor chimeric and fusion proteins |
| 09/20/2001 | WO2001068705A2 Il-17 receptor like molecules and uses thereof |
| 09/20/2001 | WO2001068704A2 G-protein coupled receptors |
| 09/20/2001 | WO2001068703A1 Human histamine h3 gene variant-2 |
| 09/20/2001 | WO2001068700A2 Regulation of human substance p-like g protein-coupled receptor |
| 09/20/2001 | WO2001068699A2 Regulation of human neuropeptide y-like g protein-coupled receptor |
| 09/20/2001 | WO2001068697A2 Methods and compositions for immunoregulation |
| 09/20/2001 | WO2001068696A1 Human immune response proteins |
| 09/20/2001 | WO2001068695A2 Factor-h related protein 5 (fhr-5) and antibodies thereto |
| 09/20/2001 | WO2001068694A1 A novel polypeptide - human hexokinase protein 10 and a polynucleotide sequence encoding the same |
| 09/20/2001 | WO2001068693A1 A novel polypeptide, human cannabinoid receptor protein 7 and the polynucleotide encoding thereof |
| 09/20/2001 | WO2001068692A1 A novel polypeptide - human retinoblastoma-binding protein 9 and a polynucleotide sequence encoding the same |
| 09/20/2001 | WO2001068691A1 A novel polypeptide, human fd11 and the polynucleotide encoding there of |
| 09/20/2001 | WO2001068690A1 A new polypeptide-human zinc finger protein 15 and the polynucleotide encoding it |
| 09/20/2001 | WO2001068689A1 A novel polypeptide, human hypoxia-inducible factor 1 alpha subunit 13 and the polynucleotide encoding thereof |
| 09/20/2001 | WO2001068688K1 A novel polypeptide, a human protein kinase tak1-27 and the polynucleotide encoding the polypeptide |
| 09/20/2001 | WO2001068688A1 A novel polypeptide, a human protein kinase tak1-27 and the polynucleotide encoding the polypeptide |
| 09/20/2001 | WO2001068687A1 A novel polypeptide-clathrin light chain 21 and the polynucleotide encoding said polypeptide |
| 09/20/2001 | WO2001068686A1 A novel polypeptide-human mannosephosphate isomerase 16 and the polynucleotide encoding said polypeptide |
| 09/20/2001 | WO2001068685A1 A novel polypeptide-human sperm specific protein em1,em6-48 and the polynucleotide encoding said polypeptide |
| 09/20/2001 | WO2001068684A1 A novel polypeptide-human protocadherins 14 and the polynucleotide encoding said polypeptide |
| 09/20/2001 | WO2001068682A1 Self antigen vaccines for treating b cell lymphomas and other cancers |
| 09/20/2001 | WO2001068677A2 Derivatives of breast canacer antigen her-2 for therapeutical use |
| 09/20/2001 | WO2001068674A2 Preparation of recombinant proteins containing repeating units |
| 09/20/2001 | WO2001068673A1 Oligonucleotide analogues, methods of synthesis and methods of use |
| 09/20/2001 | WO2001068670A2 Family of mechanically sensitive human potassium channels activated by polyunsaturated fatty acids and use thereof |
| 09/20/2001 | WO2001068668A1 Atm mutations in breast cancer |
| 09/20/2001 | WO2001068667A1 Arrest of proliferation of highly glycolytic tumors |
| 09/20/2001 | WO2001068255A2 Microarray spotting instruments incorporating sensors |
| 09/20/2001 | WO2001068147A2 Synthetic oligonucleotides as inducers of erythroid differentiation |
| 09/20/2001 | WO2001068146A2 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| 09/20/2001 | WO2001068144A2 Biodegradable immunomodulatory formulations and methods for use thereof |
| 09/20/2001 | WO2001068143A2 Immunomodulatory formulations and methods for use thereof |
| 09/20/2001 | WO2001068131A1 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2 |
| 09/20/2001 | WO2001068130A1 Method and composition for treating airway hyperresponsiveness |
| 09/20/2001 | WO2001068122A2 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity 'mia' |
| 09/20/2001 | WO2001068120A2 Uses of bombesin receptor 3 |
| 09/20/2001 | WO2001068117A2 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections |
| 09/20/2001 | WO2001068116A2 Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections |
| 09/20/2001 | WO2001068109A1 Modified factor viii |
| 09/20/2001 | WO2001068078A2 Immunostimulatory polynucleotide sequences for use in suppressing hepatitis virus infection |
| 09/20/2001 | WO2001068077A2 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections |
| 09/20/2001 | WO2001067861A1 Materials and methods for the regeneration of plants from cultured plant tissue |
| 09/20/2001 | WO2001067855A2 Transgenic mice containing targeted gene disruptions |
| 09/20/2001 | WO2001067854A1 Chimeric animal model susceptible to human hepatitis c virus infection |
| 09/20/2001 | WO2001049745A9 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 09/20/2001 | WO2001042439A8 Molecular display on multimeric protein scaffolds derived from the e2 component of the alpha-ketoacid dehydrogenase |
| 09/20/2001 | WO2001034791A3 Chemoreceptors in plant parasitic nematodes |
| 09/20/2001 | WO2001031033A3 Protease from lucila sericata and its use in treatment of wounds |
| 09/20/2001 | WO2001030851A3 Idiotype vaccines |
| 09/20/2001 | WO2001029070A8 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 09/20/2001 | WO2001020018A8 Diagnosing and treating arthritic disorders |
| 09/20/2001 | WO2001019851A3 Opaminergic neuronal survival-promoting factors and uses thereof |
| 09/20/2001 | WO2001019850A3 Nrage nucleic acids and polypeptides and uses thereof |
| 09/20/2001 | WO2001018192A3 Synthetic vectors, transgenic plants containing them, and methods for obtaining them |
| 09/20/2001 | WO2001018170A3 Conditional inhibition of vegetative propagation |
| 09/20/2001 | WO2001018051A3 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 09/20/2001 | WO2001016338A3 Production of cellulase in plastids of transgenic plants |
| 09/20/2001 | WO2001016317A3 Polycyclic aromatic hydrocarbon induced molecules |
| 09/20/2001 | WO2001016165A3 Apoptin-associating protein |
| 09/20/2001 | WO2001014593A3 A method for producing quality assured biological sample and composition containing the same |
| 09/20/2001 | WO2001014581A3 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 09/20/2001 | WO2001014566A3 Enzymatic synthesis of deoxyribonucleosides |